A report released today by Baader Wertpapierhandelsbank about Brenntag (ETR:BNR) ups the target price to 48.00EUR
- Updated: October 1, 2016
Displaying a price of 48.85EUR, Brenntag (ETR:BNR) traded 0.00% even on the day. With the last close up 0.00% from the two hundred day moving average, compared to the Standard & Poor's 500 Index which has decreased -0.01% over the same time period. Brenntag has recorded a 50-day average of 0.00EUR and a two hundred day average of 0.00EUR. 0 shares of Brenntag traded, down from an average trading volume of 0
In a report issued Friday September 30, 2016 Baader Wertpapierhandelsbank raised the target price of Brenntag (ETR:BNR) to 48.00EUR stating a potential downside of -0.02%.
Previously on 9/29/2016, Kepler Cheuvreux released a statement for Brenntag (ETR:BNR) raised the target price from 0.00EUR to 52.00EUR that suggested an upside of 0.06%.
See Chart Below
With a total market value of 0 EUR, Brenntag has with a 52 week low of 0.00EUR and a 52 week high of 0.00EUR .
General Information About Brenntag (ETR:BNR)
Brenntag AG is a Germany-based company active in the field of full-line chemical distribution. It provides business-to-business distribution solutions for industrial and specialty chemicals. The Company purchases and stores large-scale quantities of industrial and specialty chemicals and repackages them into smaller quantities. In addition, the Company also offers additional services, including delivery, product mixing, blending, repackaging, micronization and fine milling, inventory management and drum return handling, as well as technical and laboratory services for specialty chemicals. The Company offers its products to a range of market industries, such as adhesives, paints, oil & gas, food, water treatment, personal care and pharmaceuticals. The Company operates through a network with more than 450 locations in Europe, North and Latin America, and in the Asia Pacific region. Its subsidiaries include, among others, Quimicas Merono SL.
Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with MarketBeat.com's FREE daily email newsletter.